chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient complained of a fever that lasted over a week, body aches and pains that lasted two weeks starting almost immediately after the vaccination.  She said she was bedridden most of that time.
dose of Boostrix / that was/nonviable after an excursion; This case was reported by a physician via call center representative and described the occurrence of incorrect storage of drug in a 11-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 5E43J, expiry date 30th August 2022) for prophylaxis.   On 18th June 2021, the patient received Boostrix. On 18th June 2021, unknown after receiving Boostrix, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.  Additional case details were reported as follows: The patient was given a dose of Boostrix that was deemed nonviable after a temperature excursion, which led to incorrect storage of drug.  No symptoms reported. The reporter consented to follow up. This case was 3rd from 6 case reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021142817:Same reporter US-GLAXOSMITHKLINE-US2021142812:Same reporter US-GLAXOSMITHKLINE-US2021142816:Same reporter US-GLAXOSMITHKLINE-US2021142813:Same reporter US-GLAXOSMITHKLINE-US2021142818:Same reporter
This spontaneous report was received from a nurse refers to a 19 year old female patient. No concurrent condition or medical history was reported. On an unknown date in 1996 or 1997, the patient was vaccinated with 3 dose series of RECOMBIVAX HB (dose and route of administration not provided). No concomitant therapy was reported. The patient had titers withdrawn on an unknown date and serological testing showed negative titers i.e. no immunity. The patient was given then 2 booster dose of RECOMBIVAX HB on 28-AUG-2015 and 02-DEC-2015. On an unknown date, recently, the patient had titers drawn again which also came back negative. The reporter inquires if the patient should receive another dose or another series of doses of RECOMBIVAX HB and if so when they should be administered to the patient. The outcome of the event was unknown. The reporter considered event to be related to suspect therapy. No product quality issue was involved. Additional information has been requested.
Itchy and bumpy face started on February 17th.  Woke up on the 18th with a swollen face and continued with bumps and itchiness.  Went to Urgent Care on February 20th and started steroids.  The swelling increases while I am sleeping.
Patient stated that starting the day after vaccination, she developed an itchy rash on chest and arms. She was told to take Benadryl 25mg every 4 to 6 hours in the evening and use 2% cream during the day until she can seek medical treatment
Patient presented to ED on 7/24/2021 with 1 week of fatigue and malaise. Patient is fully vaccinated. Patient treated for COVID-19 and discharged on 7/29/2021.
headache, fever (98.6 - 101.3F), whole-body pain, arm swelling(very big), arm pain, tiredness
Within 5 min of receiving the shot there was a minor itch such as a tag rubbing my neck.  I am not an itchy person so I noticed it right away, but ignored it. Then with in the 10 minutes I felt an elevated breathing as if one were hyperventilating. I told myself that I was probably anxious any that too went away within 3+ minutes. The itch continued to increase after leaving the site, and by 6 pm it had become like an ?morphine drip? type itch . An itch that you get after a procedure in a hospital and they give you opioids. An annoyance but harmless. This has continued for 3 days.  After the  first day, I asked a pharmacist what would be recommended for the itch. She suggested benedryl. It worked for a short period of time 1 1/2 hours.  Calamine lotion was also tried with a cool shower.  After  the 3 day I went to the urgent care  where no testing was done, but I was prescribed hydroxyline
Patient with 2 Moderna vaccinations, last dose 05/05/21, who admitted with COVID complications.  Provider discharge note below:  "Reason for Admission:  62 year old male with past medical history significant for nicotine dependence, asthma, obstructive sleep apnea, chronic heart failure with reduced EF in setting of nonischemic dilated cardiomyopathy, status post AICD, left renal infarct due to thromboembolism on chronic anticoagulation, failed right total right knee replacement with removal of prosthesis on suppressive antibiotics, chronic kidney disease stage 2, chronic pain on chronic opiates, anxiety on chronic benzodiazepines and depression presented with acute respiratory failure with hypoxia and viral sepsis in setting of COVID 19 pneumonia.     Brief Summary of Hospital Stay: (Include Significant Findings and Invasive Procedures)  Patient required up to 100% FiO2 and 15 liter Venturi mask alternating with non-rebreather. He was started on Decadron while continued on home Eliquis.  Remdesivir was not used in setting of worsening renal failure.   With persistent hypoxia, steroids were escalated to Methylprednisolone 1 mg/kg daily in two divided doses.  Patient's oxygen requirements slowly decreased and oxygen was weaned to 4 liters by nasal cannula by time of discharge.  He was discharged on a prednisone taper.    On admission, patient had worsening renal failure with hyperkalemia.  Patient received a small IV Fluid bolus and home Entresto and loop diuretics were held.  Patient was started on Lokelma three times daily.  Eventually renal function returned towards baseline and patient was started on IV Lasix to promote negative fluid balance and then was transitioned back to his home Torsemide prior to discharge.  Patient was normotensive at time of discharge off home Entresto.    Patient was also started on Tamsulosin in the setting of urinary retention with symptoms resolving prior to discharge.    Issues Requiring Follow Up: (Who, what, when, and how communicated?) Follow-up resolution of respiratory failure in setting of continued recovery from COVID 19 pneumonia with PCP; follow-up smoking cessation with PCP; consider referral to pulmonology if oxygen requirement persists; follow-up with cardiology regarding chronic heart failure with reduced ejection fraction (Entresto held due to worsening kidney failure and hyperkalemia); follow-up failed right knee prosthesis on suppressive antibiotics with Orthopaedics; follow-up right hand numbness if persists with neurology; follow-up other issues with PCP"
He presented to the emergency department with chief complaint of shortness of breath in setting of known COVID-19 infection. He reports last night he had oxygen levels in the 80s, he borrowed a family friend's oxygen (unclear if this does not sound like it was an oxygen tank but rather some type of device that concentrated it " from the air") and continued feel hypoxic so he came into the ER. He was hypoxic upon arrival, had a can of concentrated oxygen that he was using in route. He feels very dyspneic and is dyspneic with conversation. He denies chest pain. He denies any lower extremity swelling or edema or calf pain. He reports that his fevers have improved, cough is improved but dyspnea is worse.    Per chart review, patient reported developing myalgias, generalized weakness, cough, and fever on 1/27. He took a home COVID test the following day that resulted positive. He noted his family members were also sick, however, they were improving and he had worsened. He presented to ED on 2/1 due to feeling more short of breath. Labs showed elevated D-dimer. CT chest was performed showing mild evidence of inflammatory COVID pneumonia, no PE. Sats were 93% at worst. Patient was discharged in stable condition with dexamethasone x10 days. He represented to ED on 2/2 with worsened shortness of breath. A home oximeter read sats between 88-90% at rest and 82% with exertion. Patient had sats in mid to high 90s in the ED and did an ambulation trial without desaturation. He had a chest x-ray showing stable infiltrates. Patient was sent home with an albuterol inhaler and advised to continue taking dexamethasone and monitoring saturations. He out of the window for Paxlovid and did not get monoclonal ABX.
Uneventful pregnancy, close to 30 weeks by vaccination date. Expected due date February 22. Received vaccine at prenatal visit. Around Christmas, felt warmness in abdomen area. By 12/29 did not feel much baby movement so went to get it checked out. Baby was stillborn 12/29/2015.
I have had unexplainable moderate to severe pelvic pain which have been ongoing  since 8/1/2021. I have seen 5 doctors who had run all possible blood and urine tests, and conducted hysteroscopy, pelvic ultrasound, and CT scan. All tests and procedures came back normal and none could explain the underlying causes of my pain. The only possible explanation is this could be related to the COVID  vaccine
Muscle aches and pains  Some severe   Calf pain, tired still, chills still, The pains keep changing to different parts
1003-c/o "feeling funny" 1005-states heart racing, chest "feels heavy" SpO2-100%, HR 90, BP 120/65 1008-pt refuses benadryl, doesn't want to feel "sleepy". Denies difficulty breathing, ShOB, no trouble swallowing SpO2-100%, HR-86 1010-Patient shaking, requesting benadryl. Benadryl Elixir given, 25 mg, PO. SpO2-100% HR-81 1012-reports chest heaviness improving, throat feels sore, no difficulty breathing, continues to shake, covered with blankets, refusing epi 1014-reports "feel funny all over" Rapid Response Team called. SpO2 100%, HR 79 1015-attempt to start 20g IV without success 1017-0.3 mg Epi IM given, rapid response team here. 1020-SpO2 99%, HR 87, patient agrees to be transported by W/C to ED 1024-patient transported to ED accompanied by spouse and rapid response team to ED room 12. 1530-attempt to call to check on patient. LVM to call back.
fever blister in her lower lip; roof of mouth/gum line is sensitive; roof of mouth/gum line is numb; metallic taste; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Mar-2021 and was forwarded to Moderna on 08-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of LIP BLISTER (fever blister in her lower lip), STOMATITIS (roof of mouth/gum line is sensitive), HYPOAESTHESIA ORAL (roof of mouth/gum line is numb) and DYSGEUSIA (metallic taste) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included Hashimoto's disease. Concurrent medical conditions included Drug allergy (Patient have allergy towards sulfa drug and hydrocodone.), Latex allergy and Seasonal allergy. Concomitant products included ALLOPURINOL for Arthritis gouty, METOPROLOL for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) for Hypothyroidism, CALCIUM, MAGNESIUM and ZINC for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced LIP BLISTER (fever blister in her lower lip), STOMATITIS (roof of mouth/gum line is sensitive), HYPOAESTHESIA ORAL (roof of mouth/gum line is numb) and DYSGEUSIA (metallic taste). At the time of the report, LIP BLISTER (fever blister in her lower lip), STOMATITIS (roof of mouth/gum line is sensitive), HYPOAESTHESIA ORAL (roof of mouth/gum line is numb) and DYSGEUSIA (metallic taste) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No laboratory details was given.  After 15 minutes, patient experienced a fever blister in her lower lip (sometimes caused by HPV1 or stress), roof of mouth/gum line is sensitive and numb (swelling/blistering) and metallic taste. Symptoms are still evident today and patient states that it is not severe.   Treatment Took abreva cream on the fever blister
had joint pain for 6 weeks and he still has it; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (had joint pain for 6 weeks and he still has it) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 UNK. On an unknown date, the patient experienced ARTHRALGIA (had joint pain for 6 weeks and he still has it). At the time of the report, ARTHRALGIA (had joint pain for 6 weeks and he still has it) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter. The medical history was not provided by the reporter. Treatment information was not provided by the reporter.
left arm had knot size of an egg at day 5, warm to touch, hives within the knot, red, itchy.  Continued for 10 days with decreasing symptoms each day. Redness and itchiness spread in size and eventually travelled down to elbow before going away.
Employee waited for 15 minutes after injection in the Department, 40 minutes after the employee left she called employee health and was instructed to return to the hospital ED if she was able.  Dr.  and the ED physician evaluated her. She had peri-oral numbness, and some cheek numbness, no motor deficits.  SBP was 200 in ED.  Single dose of Catapress and then improved B/P.  D/C to home. 12/17/2020 - AM mild chin numbness - everything else resolved. B/P remained stable 12/18/2020 - resolved
developed shingles; 45-year-old female patient  was administrated with Shingrix; This case was reported by a nurse via call center representative and described the occurrence of shingles in a 45-year-old female patient who received Herpes zoster (Shingrix) (batch number 9LG54, expiry date 25th September 2021) for prophylaxis.   Previously administered products included Shingrix (1st dose received on 10th October 2019, reference case US2021034614).   On 21st January 2020, the patient received the 2nd dose of Shingrix. On 21st January 2020, less than a day after receiving Shingrix, the patient experienced shingles and inappropriate age at vaccine administration. On an unknown date, the outcome of the shingles was recovered/resolved and the outcome of the inappropriate age at vaccine administration was unknown.   It was unknown if the reporter considered the shingles to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix vaccine at the age of 45 years old, which led to inappropriate age at vaccine administration. The patient developed shingles after 2nd dose and she was recovered from the shingles. The reporter consented to follow-up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021034614:same reporter
About 15- 30 minutes after moderna booster vaccination developed few hives down arm and at injection side. Took zyrtec and resolved. Sx reappeared 12/2 with hives left arm and shoulder, to back of neck, behind ears bilat, abd. Took zyrtec and improved. Returned about 6 hours later more wide spread. Started claritin 20 mg and pepcid 20 mg BID as recommended by dermatology in my office. I have been taking this for almost 2 weeks now. If I miss a dose hives come back. Also if I get too warm or something irritating touches me they come back. I have never had hives before.
chills in arms; tiredness; fever of 101; some nausea; felt unwell; a little constipation; soreness in left arm; not feeling hungry; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 09Apr2021 at 12:45 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high and high cholesterol. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date and atorvastatin (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have a history of allergies to medications, food or other products. On 10Apr2021 at 01:00, the patient noticed chills in arms, tiredness, had fever of 101, some nausea, felt unwell, a little constipation, soreness in left arm. Also, woke up not feeling hungry, but was able to eat something by 10:00. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcomes of the events chills in arms, tiredness, had fever of 101, some nausea, felt unwell, a little constipation, soreness in left arm was not recovered at the time of this report and that of feeling hungry was resolved on 10Apr2021 at 10:00 am.   No follow-up attempts are needed. No further information is expected.
Moderna COVID-19 Vaccine EUA Injection site became red, hot to the touch, tender and raised.  Concerned because it has developed one week after vaccine was originally administered. These symptoms did not appear when the vaccine was first administered.
Patient's mom called, couple hours after FLUMIST had facial redness/swelling, "throat felt funny" given OPAPRED at ER. Couldn't have BENADRYL due to seizure disorder.
Tested positive (for COVID-19) on a Rapid Test performed today; Congested/congestion; This is a spontaneous report from a non-contactable consumer (patient's mother). A female patient of unspecified age received first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number and expiry date: unknown), via an unspecified route of 27Apr2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Question asked if the Pfizer COVID-19 vaccine, received by her daughter on 27Apr2021 (first dose) can change her rapid test to positive for COVID-19. It is reported that the patient woke up yesterday (May2021) (8 days after first shot) very congested and tested positive (for COVID-19) on a Rapid Test performed today (06May2021), the only symptom her daughter had congestion. The patient underwent lab tests and procedures which included on 06May2021 Rapid test for COVID-19 result positive and PCR Test today and will get back the results in a few days, to know for sure. Outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Fatigue, body aches, swelling injection site, chills, cough, runny nose, loss of smell,headache
Pfizer vaccine was reconstituted with sterile water instead of normal saline and administered.  Patient has not reported any adverse effects
Shortness of breath, rapid heart rate increased bp, dizziness, shaky, tightness in chest, sweaty. " Has Mal de Debarquement syndrome".
Pt received 0.2 mL of Pfizer 5y-11y Covid-19 (Orange Cap) vaccine that was not diluted.  No adverse reactions observed after vaccination.
No reaction to DTAP or IPV or COMVAX given at 2 months of age. At 4 months of age, DTAP, IPV, COMVAX and PREVNAR given and within 4 hours, pt had a fever to 102F and vomiting. Symptoms lasted for 48 hours. At 6 months visit, the pt got DTAP, IPV and COMVAX and had no reaction, fever or vomiting.
Information has been received from a licensed visiting nurse via a nurse practitioner. The nurse practitioner was told by a friend that a female patient was vaccinated with Gardasil and two weeks alter developed a blood clot. Subsequently the patient died. The cause of death was from the blood clot. The reporting licensed visiting nurse considered the blood clot to be immediately life-threatening and disabling. Additional information has been requested.
Patient noted very red area on enitre upper arm. Patient stated arm was very swollen and she could not sleep on it for days. Also, states that arm hurt quite badly.
Received 5 vaccines (Tdap, MCV4, Gardasil, HepA, flu) in office, returned to office after going across the hall to get brothers bloodwork done, (child did not actually have blood drawn), where child had an event where he turned pale, became sweaty, lightheaded, and nauseated. Was standing still when sx started. Never had syncopal events prior, and no exertional syncope, dizziness or chest pain. Hadn't had anything to eat that day. Oon arrival back to office c/o periumbilical abdominal pain. No loss of consciousness in lab, able to walk in to our office, but here with decreased arousability, not responding appropriately to commands, alert to name and day of week, not place. Stable glc (103). Irregular heart rate (c/w PVCs) strength 5/5, symmetric and full facial movements, perrl, eomi. Monitored in office for > 20 minutes, without return to normal consciousness, so called 911 and transported to ER.
Patient requested a flu vaccine, but a Tdap (boostrix) was administered instead. The administering pharmacist grabbed the wrong vaccine. Fluarix and Boostrix vaccines were next to each other with the same looking boxes. Patient was contacted immediately upon discovering the error. She did not report any adverse reactions or issues.
Inmate had two falls in a 24 hour period.  Inmate complains of fatigue, dizziness, body aches and  weakness.  Inmate also reports increased urination and incontinent episodes.  Inmate had a temperature of 102 F.
got covid; got covid; This is a spontaneous report from a Pfizer Sponsored Program from a contactable consumer. A patient of unspecified age and gender received 1st dose of bnt162b2, via an unspecified route of administration in Feb2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient got covid on an unspecified date with outcome of unknown. The patient missed second dose due to covid. Patient would still like to receive second dose.   Information on the lot/batch number has been requested.